Literature DB >> 4302630

Motor nerve terminals as the site of initial functional changes after denervation.

M Okamoto, W F Riker.   

Abstract

For the cat soleus nerve-muscle system, motor nerve section 48 hr prior to in situ experiment causes certain characteristic transmission losses. Responses to repetitive stimulation are sharply altered: The capacity to transmit iterative stimulation is severely reduced; post-tetanic potentiation and the post-tetanic repetition of soleus nerve terminals responsible for it are also greatly impaired; a phenomenon of post-tetanic depression was frequently observed. However, function of the extramuscular axons appears normal and single impulse transmission is usually not seriously affected. The loss of reactivity to repetitive stimulation has been traced to soleus motor nerve terminals. In view of these data and the known absence of denervation hypersensitivity at this time, the earliest functional failure may be said to occur in the unmyelinated terminals. This subacutely denervated preparation therefore offers a simple means of evaluating motor nerve terminal responsiveness.

Entities:  

Mesh:

Year:  1969        PMID: 4302630      PMCID: PMC2202894          DOI: 10.1085/jgp.53.1.70

Source DB:  PubMed          Journal:  J Gen Physiol        ISSN: 0022-1295            Impact factor:   4.086


  6 in total

1.  AXONAL MIGRATION OF PROTEINS IN THE CENTRAL NERVOUS SYSTEM AND PERIPHERAL NERVES AS SHOWN BY RADIOAUTOGRAPHY.

Authors:  B DROZ; C P LEBLOND
Journal:  J Comp Neurol       Date:  1963-12       Impact factor: 3.215

2.  Migration of proteins along the axons of the sciatic nerve.

Authors:  B DROZ; C P LEBLOND
Journal:  Science       Date:  1962-09-28       Impact factor: 47.728

3.  Physiological and structural changes at the amphibian myoneural junction, in the course of nerve degeneration.

Authors:  R BIRKS; B KATZ; R MILEDI
Journal:  J Physiol       Date:  1960-01       Impact factor: 5.182

4.  The ultrastructure of normal and denervated neuromuscular synapses in mouse gastrocnemius muscle.

Authors:  J F REGER
Journal:  Exp Cell Res       Date:  1957-06       Impact factor: 3.905

5.  THE MECHANISMS OF POST-TETANIC POTENTIATION IN CAT SOLEUS AND GASTROCNEMIUS MUSCLES.

Authors:  F G STANDAERT
Journal:  J Gen Physiol       Date:  1964-05       Impact factor: 4.086

6.  POST-TETANIC REPETITIVE ACTIVITY IN THE CAT SOLEUS NERVE. ITS ORIGIN, COURSE, AND MECHANISM OF GENERATION.

Authors:  F G STANDAERT
Journal:  J Gen Physiol       Date:  1963-09       Impact factor: 4.086

  6 in total
  7 in total

1.  Calpains mediate axonal cytoskeleton disintegration during Wallerian degeneration.

Authors:  Marek Ma; Toby A Ferguson; Kathleen M Schoch; Jian Li; Yaping Qian; Frances S Shofer; Kathryn E Saatman; Robert W Neumar
Journal:  Neurobiol Dis       Date:  2013-03-28       Impact factor: 5.996

2.  Interaction between motor axons from two different nerves reinnervating the pectoral muscle of Xenopus laevis.

Authors:  C Haimann; A Mallart; J T Ferré; N F Zilber-Gachelin
Journal:  J Physiol       Date:  1981-01       Impact factor: 5.182

3.  Motor nerve terminal defect following tenotomy.

Authors:  M Vincent-Ablazey; T Baker; H E Lowndes
Journal:  Experientia       Date:  1978-11-15

Review 4.  Neuroprotective actions of glucocorticoid and nonglucocorticoid steroids in acute neuronal injury.

Authors:  E D Hall
Journal:  Cell Mol Neurobiol       Date:  1993-08       Impact factor: 5.046

5.  Neurotoxicology of vincristine in the cat. Electrophysiological studies.

Authors:  B D Goldstein; H E Lowndes; E Cho
Journal:  Arch Toxicol       Date:  1981-11       Impact factor: 5.153

6.  Is the contractile response to exogenous acetylcholine due to a presynaptic effect?

Authors:  C Y Lee; M C Tsai
Journal:  Br J Pharmacol       Date:  1976-08       Impact factor: 8.739

7.  The effects of phenylmethanesulfonyl fluoride on delayed organophosphorus neuropathy.

Authors:  T Baker; H E Lowndes; M K Johnson; I C Sandborg
Journal:  Arch Toxicol       Date:  1980-12       Impact factor: 5.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.